This work is part of a study to determine the economic feasibility of using mutant strains of Escherichia coli for conversion of cheap carbon and nitrogen sources into tryptophan. Relatively little success has been obtained in earlier approaches to this problem (2, 14, 15, 18, 21, 26) . Thus, for this study we decided to investigate the effects of a wide range of mutations on the production of tryptophan in the hope of providing a firm basis for a continuing experimental approach to this problem. This paper is primarily concerned with the genetically determined limitations which restrict the flow of intermediates down the biosynthetic pathways leading to tryptophan and with the steps that can be taken to overcome these restrictions. A summary of the restrictions that are most relevant to this report is given in Fig.  1 . Since the biochemical background for this problem is extensive, the reader is referred to recent reviews for detailed documentation (3, 9, 16, 19, 25, 27) . Figure 1 reveals three major influences affecting the overall conversion of erythrose 4-phosphate and phosphoenolpyruvate to tryptophan.
First, the syntheses of 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase (EC 4.1.2.15) isoenzymes Tyr, Phe, and Trp, shikimate kinase (EC 2.7.1.71), and all the enzymes of the terminal pathway of tryptophan synthesis are repressible by one or more of the aromatic amino acids. This repression involves the apo-repressor proteins apo-trpR and apotyrR, which are the products of the genes trpR and tyrR, respectively (3, 4, 11) . Second, the activities of the DAHP synthases (19) and the anthranilate aggregate (10, 18, 27) , which is involved in catalyzing the first two steps of the tryptophan pathway, are each inhibitable by one of the aromatic amino acids. Third, diversion of chorismate down branch pathways other than the tryptophan pathway may occur, particularly to tyrosine and phenylalanine biosynthesis.
In this paper we provide details as to how removing each one of these restrictions influ- Fig. 1 , with metabolism of tryptophan after it has been synthesized, and also with environmental factors such as pH and temperature.
(A preliminary report of some of our findings was presented at the Third International Symposium on the Genetics of Industrial Microorganisms, Madison, Wisconsin, June 1978.) MATERIALS AND METHODS Unless otherwise specified, the materials and methods were as described previously (23) .
Organisms. All (12) and was kept between 20 and 100% of saturation during the experiments described in this report.
Measurement of cell mass. Cell mass was determined as described by Niedhart et al. (17) , except that turbidity measurements were made at 670 nm.
Analysis of culture fluids. Immediately after sampling, culture fluids were kept between 0 and 4°C.
Cells were separated by centrifugation, and the supernatant fluids were analyzed.
Tryptophan was determined by the colorimetric method of Udenfriend and Peterson (24) . It was found that treatment of samples with trichloroacetic acid solutions to extract tryptophan from cells and to precipitate protein was redundant, and this step was generally omitted. Preliminary tests suggested that serious interference by compounds other than tryptophan (2,3-dihydroxybenzoate, indole, anthranilate) in the culture fluids was unlikely to be significant with this assay system.
Glucose was determined by the hexokinase reaction (13) . (1) . Unless otherwise specified, mutant alleles cause loss of ability to produce a functional protein. The genes aroF, aroG, and aroH are, respectively, the structural genes for DAHP synthase Tyr, Phe, and Trp; trpE codes for anthranilate synthase activity; the tyrA and the pheA genes code for the enzymes involved in the first two steps of the tyrosine and phenylalanine pathways; tna determines ability to produce tryptophanase; tyrR and trpR are genes concerned with repression of the synthesis of enzymes concerned with aromatic biosynthesis, and trpS codes for tryptophanyl-transfer ribonucleic acid synthetase. Other genes are: nadA, gene concerned with nicotinamide synthesis; gal, galactose utilization; pyrF, pyrimidine (uracil) synthesis; thr, threonine synthesis; leu, leucine synthesis; pro, proline synthesis; lac, lactose utilization; his, histidine synthesis; arg, arginine synthesis; thi, thiamine synthesis; tonB, gene affecting a variety of membrane functions, including those relating to bacteriophage )80 and colicin V sensitivity; malT, gene concerned with maltose utilization and bacteriophage A sensitivity; rif, resistance to rifamycin; aroB, gene involved in conversion of DAHP to 3-dehydroquinate; aroP, transport of aromatic amino acids.
'All transductions listed involved bacteriophage PIkc.
'Alleles aroF394, aroG397, aroH371, trpE382, and trpE472 all cause the respective enzymes encoded by these genes to be desensitized to end product inhibition.
d F-merogenote F521 is derived from F123. The latter F-merogenote carries the genes tonB+ trp+ tyrR+. As a result of gene conversion and appropriate selections, the derivative F521 was obtained and characterized as being F123 trpE382 tyrR366. (Allele trpE382 is described in footnote c.) ePlasmid pUM101 is derived from the ColV-trp plasmid of Fredericq (7) . It was isolated by a procedure involving selection of 5-methyltryptophan-resistant mutants, which have the property of transferring 5-methyltryptophan resistance in linkage with plasmid transfer, and encodes an anthranilate aggregate that is desensitized to tryptophan inhibition. It carries trpE472.
Enzyme assays. Details of the harvesting, washing, and disruption of cells have been given previously, as have the details of many of the assays (23) .
For the anthranilate synthase assay the reaction mixture consisted of 1 Table 2 ; to facilitate consideration of these results, they are discussed below according to the groups into which the strains were classified.
Strains with mutations affecting only chorismate supply (group I). Group I strains all carry mutations affecting the availability of chorismate for tryptophan synthesis, but they do not have changes directly affecting either repression of the synthesis of the tryptophan pathway enzymes or feedback inhibition of the anthranilate aggregate.
One of this group of strains is JP2235. The restrictions that normally operate to limit conversion of erythrose 4-phosphate and phosphoenolpyruvate to DAHP, and consequently limit conversion to chorismate, are lacking in this strain. The absence of these controls is a consequence of (i) lack of functional apo-tryR (and thus the strain produces derepressed levels of DAHP synthase Try) and (ii) the presence of an aroF394 mutation rendering the DAHP synthase Tyr isoenzyme resistant to tyrosine inhibition. The strain also has genetic blocks that prevent utilization of chorismate in the biosynthesis of tyrosine and phenylalanine; hence, in this strain a ready supply of chorismate for tryptophan formation is ensured. This strain is the only member of group I in which significant tryptophan overproduction was detected ( Table  2 ). The apparent ineffectiveness offeedback control of the anthranilate aggregate in preventing overproduction of tryptophan by this strain is readily explained by the well-known competitive interaction chorismate and tryptophan at this enzyme (10, 18, 27) .
Strains with trp regulatory mutations (group H). There are two strains in group II (Table 2) ; one lacks functional apo-trpR and the other has a feedback inhibition-resistant anthranilate aggregate, but neither differs from the parental reference strain at loci which would affect supply of chorismate. In contrast to the group I strain just discussed (JP2235), neither of these group II strains significantly overproduces tryptophan.
Strains affected in both chorismate supply and its conversion to tryptophan (group III). Group III consists of those strains that carry both (i) mutations that would affect chorismate formation or its diversion to tyrosine and phenylalanine synthesis, and (ii) mutations The culture medium used was medium MMB with 20 g of glucose per ml. From growth curves that were determined for some of the strains, it was estimated that each culture was in stationary phase for 10 to 15 h.
b Strain JP2227 also carries the mutations aroG, aroH, and tna, as do all strains listed except JP2239, which is aroG aroH tna+. ' The basis for grouping the strains is described in the text. d As previously mentioned, alleles aroF392 and trpE382 confer feedback resistance on the enzymes DAHP synthase Tyr and anthranilate synthase, respectively.
'Some of the properties of JP2241, a trpE derivative of strain JP2235, are discussed by Tribe et al. (23); its culture fluids contained significant amounts of chorismate. g Tests for cross-feeding showed that strain JP2275, but not strain JP2276, overproduced significant amounts of tyrosine and phenylalanine.
directly affecting regulation of the tryptophan pathway. Thus, strains of group III combine characteristics of both group I and group II. The group is further divided into group IIIa, those strains lacking apo-trpR but possessing a wildtype anthranilate aggregate, and group IlIb, those strains both lacking apo-trpR and having a feedback inhibition-resistant aggregate. It is with strains of group III, and with group IIIb strains in particular, that high values of tryptophan overproduction were obtained ( Table 2) .
The first group IIIa strain listed in Table 2 Australia, 1976) . Furthermore, in the case of strain JP2243, which was prevented from utilizing chorismate for phenylalanine or tyrosine biosynthesis, it was found that culture supernatant fluids contained almost equal amounts of tryptophan and anthranilate-like compounds. From these results it seemed evident that with strain JP2243, the capacity of cells to convert chorismate to tryptophan still represented the rate-limiting step in the overall production. Steps were therefore taken to increase the capacity of the cells to carry out these reactions.
Effect of further increases in tryptophan pathway enzyme levels in group IlIb strains. The gene trpS codes for the tryptophan-specific aminoacyl transfer ribonucleic acid synthetase. Certain mutant trpS alleles, such as trpS378 (6) , have been shown to cause elevated levels of tryptophan biosynthetic enzymes even in trpR strains. It is now believed that such mutations partially relieve attenuation of the tryptophan operon (3). Therefore, to further increase the levels of the tryptophan pathway enzymes, the trpS378 allele was introduced into one of the group IIIb strains, JP2243. To increase enzyme levels even further, cells were made diploid for the tryptophan operon genes by introducing either the F-merogenote F521 or the ColV-trp plasmid pUM101. Both of these plasmids carry mutant trpE alleles which code for anthranilate aggregates that are desensitized to inhibition by tryptophan. The effects of these alterations both on the level of tryptophan biosynthetic enzymes (indicated by specific activity of anthranilate synthase) and on the yield of tryptophan are shown in Fig. 3 . Increasing enzyme levels caused corresponding increases in the yield of tryptophan. Typical values of Y,1.
found for the trpS378 strain JP1620 were 80% (wt/wt) at 20 h.
Effects of blocks in the tyrosine and phenylalanine pathway. In marked contrast to the results obtained previously with strains JP2275 and JP2243, the presence of blocks in the phenylalanine and tyrosine pathways was found to significantly increase the yield of tryptophan in strains with very high levels of tryptophan biosynthetic enzymes ( Table 3 ). The addition of phenylalanine and tyrosine to the growth medium stimulated tryptophan production in Phe+ Tyr' strains. Although of lesser magnitude, this effect presumably is also due to an interference with the flow of chorismate along these pathways.
Kinetics of tryptophan production in batch culture. In addition to comparing different strains in shake flask culture, we carried out detailed studies on certain of the strains under controlled conditions in aerated fermentors. Figure 4 shows a representative fermentation profile obtained with one of our higher-yielding strains in one such experiment.
In this experiment we used strain NST100, 'Strains NST101 and NST103 also carry the following mutations: aroF, desensitization to tyrosine inhibition; aroG, desensitization to phenylalanine inhibition; aroH tyrR trpR trpS378 trpE, desensitization to tryptophan inhibition; pUM101+; tna. To aid comparisons, NST101 can be considered to be a nadA+ aroG which has all the genetic modifications that we describe above as being important in giving high tryptophan yields. It was cultured so that the final cell density was limited by the tyrosine content of the medium; the other nutrient requirements were in excess.
One feature of this fermentation profile that we wish to emphasize is the fact that rate of tryptophan production per mass of cells, or specific productivity [q(tryptophan)], exhibited a decline a few hours after exponential growth ceased. Similar or even more pronounced declines in q(tryptophan) were constantly observed in batch culture experiments under conditions where simple substrate depletion could be excluded as a cause.
A number of observations (especially those below) led us to consider the proposal that this change in q(tryptophan) was due to a change in an early reaction in aromatic biosynthesis. With a multiple-mutation strain (JP2486) which was found to significantly overproduce anthranilate during the exponential phase of growth, the concentration of anthranilate present in the culture fluids declined during stationary phase.
Furthermore, the addition of anthranilic acid to cultures of this strain stimulated tryptophan formation during stationary phase, but there was no corresponding stimulation during exponential phase (data not shown).
Strain JP2240, whose properties have been described in a previous report (23) 2 4 the transition from exponential to stationary phase there was a dramatic decrease in the value of q(DAHP) and also a coordinate decrease in DAHP synthase specific activity; the apparent half-life for each of these processes, as determined from a plot of the logarithm of the param-_ 6 eter against time, was 4 h in both instances.
Similar declines in DAHP synthase specific activity were consistently observed with other strains in which there was no block in the second step of the common pathway. For example, in a fermentor experiment in which strain JP2486 was used, a decline in DAHP synthase activity 08 I in cell extracts was observed concurrently with ,,, decreases in q(tryptophan). In contrast, in the same cell extracts, there were no significant changes in the specific activities of either anthranilate synthase or tryptophan synthase o (data not shown Table 4 . They make it apparent that the q(DAHP);°, cobalt content of the medium in the range tested A, DAHP. had no significant effect on enzyme stability, Fig. 4 ), can be obtained by using appropriate mutant strains of E. coli. It is interesting to compare the specific productivities we obtained with those reported for tryptophan production by other microbial processes. For example, we obtained values for specific productivity which are severalfold higher than those reported by Hagino and Nakayama (8) based on work with Corynebacterium glutamicum.
In this study we were also able to define many of the genetic alterations that have significant effects on productivity. Thus, we find that (i) overproduction of chorismate (Table 2) , (ii) blocks in the pathways diverting chorismate to tyrosine and phenylalanine biosynthesis (Table  3) , (iii) high tryptophan pathway enzyme levels ( Table 2 and Fig. 3) , and (iv) desensitization of the first steps of the tryptophan pathway to tryptophan-mediated inhibition (Table 2 ) all contribute to high productivity.
In many cases we find that mutations interact in terms of their effects on tryptophan production (see, for example, Tables 2 and 3 ). These effects were not unexpected and are readily rationalized by consideration of basic findings relating to the controls acting on these pathways (see above).
Decay of DAHP synthase activity in stationary phase. The decay in activity of the three DAHP synthase isoenzymes in the stationary phase of growth contrasts strongly with the relative stability of the other enzymes examined.
By using chloramphenicol to completely abolish synthesis of new proteins, it was possible to show that the rate of first-order decay of DAHP synthase Tyr is similar to that observed under stationary-phase conditions in the absence of chloramphenicol. This finding is consistent with the suggestion that the apparent half-life determined in the absence of chloramphenicol (at least in the case of DAHP synthase Tyr) is almost entirely a reflection of enzyme inactivation, with insignificant de novo synthesis. Moreover, the first-order decay of enzyme activity that was observed in our experiments is in accord with a mechanism whereby, after any one molecule is synthesized, there is a random chance it will be degraded (22) .
Obviously, further work is necessary to define the mechanism of this loss of DAHP synthase activity and to define conditions under which this can be prevented.
Factors limiting tryptophan yields. The results in Fig. 3 raise the possibility that further increases in tryptophan yield may be obtained with strains having even higher tryptophan pathway enzyme levels, and we are currently involved in testing this proposal. We are also investigating mutations affecting serine synthesis (which is involved in the last reaction of the pathway) and other mutations affecting transport of tryptophan across cell membranes.
On the other hand, the experiments dealing with DAHP synthase activity clearly show that in stationary phase the first reaction of the common pathway quickly becomes the rate-limiting step. Bearing this decay in mind, it would seem that the use of strains with very high exponential-phase levels of DAHP synthase activity (as we used) would offer advantages in terms of productivity, but as yet we have not been able to provide more direct evidence for this proposal. With reference to the other common pathway enzymes, it is of interest to note that even in the high-production strains the constitutive enzymes of the common pathway appear to be present at levels which are sufficient to provide chorismate at a rate which could accommodate the considerable increase in activity that occurs along the tryptophan pathway.
Overall levels of tryptophan (in grams per liter of fermentation broth) are clearly considerably influenced by the concentration of biomass in the fermentor. In relation to this it should be mentioned that in the fermentor experiment described in Fig. 4 , we deliberately restricted the final biomass concentration by adding relatively low levels of the limiting nutrient tyrosine so as to avoid problems associated with oxygen depletion. Preliminary experiments at higher cell densities (data not shown) in fermentors with better oxygen transfer characteristics suggest a proportionality between tryptophan and cell mass up to final cell densities of 10 g (dry weight) per liter. More definitive assessment of process parameters requires further experimentation at higher cell densities.
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